B-cell acute lymphoblastic leukemia (B-ALL) in CLL patients treated with lenalidomide.

7531Background: The immunomodulatory drug lenalidomide (len) has shown clinical activity in CLL. It has been associated with an increased rate of second primary malignancies (SPM) in multiple myelo...